Alembic Pharma receives USFDA approval for Tadlafil
Alembic Pharmaceuticals has received final USFDA approval for Tadalafil tablets, indicated for the treatment of erectile dysfunction. The drug will be marketed in strengths of […]
Month: April 2019
Cadila receives USFDA approval for Ambrisentan
Zydus Cadila has received final USFDA approval to market Ambrisentan tablets in in strengths of 5 mg and 10 mg in the American market. The […]